SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Medicaid Prior-Authorization Programs and the Use of Cyclooxygenase-2 Inhibitors
8 references·2 citing·40 second hop
Medicaid Prior-Authorization Programs and the Use of Cyclooxygenase-2 Inhibitors (2004)Medicaid Prior-Authorization Programs and…Powerful medicines: the benefits, risks, and costs of prescription drugs (2005)Powerful medicines: the benef…The Implications of Regional Variations in Medicare Spending. Part 2: Health Outcomes and Satisfaction with Care (2003)The Implications of Regional …The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Quality, and Accessibility of Care (2003)The Implications of Regional …The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending (2003)The Effect of Incentive-Based…Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors (2002)Outcomes of Reference Pricing…Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization (2001)Effect of a Three-Tier Prescr…Effect of a Prior-Authorization Requirement on the Use of Nonsteroidal Antiinflammatory Drugs by Medicaid Patients (1995)Effect of a Prior-Authorizati…Geographic Variation in Expenditures for Physicians' Services in the United States (1993)Geographic Variation in Expen…State Generic Substitution Laws Can Lower Drug Outlays Under Medicaid (2010)State Generic Substitution La…Is There a Relationship Between Patient Beliefs or Communication About Generic Drugs and Medication Utilization? (2009)Is There a Relationship Betwe…Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease (2008)Prescription Drug Spending Trends In The United States: Looking Beyond The Turning Point (2008)Patients’ Perceptions Of Generic Medications (2009)Why Do the Same Drugs Look Different? Pills, Trade Dress, and Public Health (2011)Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians (2015)Influencers of generic drug utilization: A systematic review (2017)Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000 (2005)The effects of prescription drug cost sharing: a review of the evidence. (2005)The Effect of Medicare Part D on Pharmaceutical Prices and Utilization (2010)Payment Restrictions for Prescription Drugs under Medicaid (1987)METHODS FOR ANALYZING HEALTH CARE UTILIZATION AND COSTS (1999)Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)Proposal of the Physicians' Working Group for Single-Payer National Health Insurance (2003)Benefits And Risks Of Increasing Restrictions On Access To Costly Drugs In Medicaid (2004)The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use (2013)Historical Origins of the Health Belief Model (1974)Latent variable models: An introduction to factor, path, and structural analysis (1987)The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient Groups (1994)Small Area Variations in Health Care Delivery (1973)Decisions with Multiple Objectives: Preferences and Value Tradeoffs. (1994)SF-36 physical and mental health summary scales : a user's manual (1994)The Association Between Income and Life Expectancy in the United States, 2001-2014 (2016)United States Health Care Reform (2016)The Effect of Drug Co-Payments on Utilization and Cost of Pharmaceuticals in a Health Maintenance Organization (1990)Estimating the Burden of Disease (1997)Effect of Increased Cost-Sharing on Oral Hypoglycemic Use in Five Managed Care Organizations (2005)What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries (2008)Pharmaceutical policies: effects of cap and co-payment on rational use of medicines (2015)Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes (1991)A Critical Analysis of Studies of State Drug Reimbursement Policies: Research in Need of Discipline (1993)Variations in Medical Care among Small Areas (1982)Dealing With Medical Practice Variations: A Proposal for Action (1984)Hospital Readmission Rates for Cohorts of Medicare Beneficiaries in Boston and New Haven (1994)The Medicare-HMO Revolving Door — The Healthy Go in and the Sick Go Out (1997)Meta-analysis: Effect of Interactive Communication Between Collaborating Primary Care Physicians and Specialists (2010)Regulatory Errors with Endogenous Agendas (2007)The logical underpinnings and benefits of pooled pharmaceutical procurement: A pragmatic role for our public institutions? (2012)Small fish, big fish: The performance effects of the relative standing in partners' affiliate portfolios (2014)The Price Ain’t Right? Hospital Prices and Health Spending on the Privately Insured* (2018)
this work references cited by second hop

References

  • 2003The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Quality, and Accessibility of Care1,536 cited
  • 2003The Implications of Regional Variations in Medicare Spending. Part 2: Health Outcomes and Satisfaction with Care1,340 cited
  • 1993Geographic Variation in Expenditures for Physicians' Services in the United States375 cited
  • 2003The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending334 cited
  • 2005Powerful medicines: the benefits, risks, and costs of prescription drugs191 cited
  • 2002Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors178 cited
  • 2001Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization161 cited
  • 1995Effect of a Prior-Authorization Requirement on the Use of Nonsteroidal Antiinflammatory Drugs by Medicaid Patients124 cited

Cited by

  • 2010State Generic Substitution Laws Can Lower Drug Outlays Under Medicaid95 cited
  • 2009Is There a Relationship Between Patient Beliefs or Communication About Generic Drugs and Medication Utilization?87 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work